Skip to search formSkip to main contentSkip to account menu

gadomer 17

Known as: gadomer-17 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Pharmacokinetic parameters corresponding to perfused microvascular volume determined from dynamic contrast‐enhanced (DCE) MRI… 
Highly Cited
2004
Highly Cited
2004
To test magnetic resonance (MR) contrast media of different molecular weights (MWs) for their potential to characterize… 
2003
2003
Rationale and Objectives:To compare enhancement patterns of gadomer-17 with those of gadopentetate dimeglumine in VX2 carcinomas… 
2002
2002
PURPOSE To evaluate the enhancement of regional lymph nodes and lymphatic vessels after intramammary injection of Gadomer-17… 
Highly Cited
2001
Highly Cited
2001
PURPOSE To compare the efficacy of an intravascular contrast agent, gadomer-17, in improving magnetic resonance (MR) imaging of… 
2001
2001
dendritic contrast agent Gadomer-17 in pigs. Purpose: To investigate the enhancement of regional lymph nodes, lymph vessels and… 
2000
2000
OBJECTIVE The objective of this study was to compare enhancement patterns of a blood-pool contrast agent, Gadomer-17, with those…